Skip to Content

ThyroKare Equine Powder

This page contains information on ThyroKare Equine Powder for veterinary use.
The information provided typically includes the following:
  • ThyroKare Equine Powder Indications
  • Warnings and cautions for ThyroKare Equine Powder
  • Direction and dosage information for ThyroKare Equine Powder

ThyroKare Equine Powder

This treatment applies to the following species:
Manufacturer: Neogen

Levothyroxine Sodium USP (0.22%)

ThyroKare Equine Powder Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

ThyroKare Equine Powder Indications

For use in horses for correction of conditions associated with low circulating thyroid hormone (hypothyroidism).

Dosage:

The suggested initial dose is 0.5 to 3.0 mg levothyroxine sodium (T-4) per 100 lbs of body weight (1 to 6 mg per 100 kg) once per day or in divided doses. Response to the administration of ThyroKare Equine Powder should be evaluated clinically until an adequate maintenance dose is established. In most horses, the total daily dose of T-4 is in the range of 6 to 36 mg. Serum T-3 and T-4 values can vary greatly among individual horses on thyroid supplementation. Dosages should be individualized and animals should be monitored daily for clinical signs of hyperthyroidism or hypersensitivity.

Administration:

ThyroKare Equine Powder can be administered by mixing the daily dose in the concentrate or by top dressing on the grain, preferably rolled or ground. To facilitate the proper adhesion of ThyroKare Equine Powder to the ration, slightly moisten the grain with water or a liquid supplement.

Active Ingredients

Each pound (453.6 g) contains:

Levothyroxine Sodium USP

0.22% (1.0 g)

One teaspoon contains:

12 mg of T-4

One tablespoon contains:

36 mg of T-4

In a palatable limestone base with vanilla flavoring.

Precaution:

Store at 20°-25°C (68°-77°F) with excursions between 15°-30°C (59°-86°F) and protect from light.

Warning

Administer with caution to animals with clinically significant heart disease, hypertension, or other complications for which a sharply increased metabolic rate might prove hazardous. Use in pregnant mares has not been evaluated.

NEOGEN® Vet

Manufactured by: Neogen Corporation, Lexington, KY 40511

859-254-1221 or 800-621-8829

animalsafety.neogen.com

Made in USA

Net Contents:

NDC:

Item No.

 

1 lb (453.6 g)

59051-9127-4

09127

L3382-0716

CPN: 1491013.6

NEOGEN CORPORATION
944 NANDINO BLVD, LEXINGTON, KY, 40511-1205
Telephone:   859-254-1221
Order Desk:   800-525-2022
Fax:   859-255-5532
Website:   http://animalsafety.neogen.com
Email:   inform@neogen.com
Every effort has been made to ensure the accuracy of the ThyroKare Equine Powder information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-10-31

Hide